Search
for

    Sort by

    Research 25

    1. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    2. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    3. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    4. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    5. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology The BMJ · 2013 · 70 citations
    6. Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review Journal of Clinical Medicine · 2021 · 34 citations
    7. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects The Journal of Sexual Medicine · 2012 · 35 citations
    8. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study BJUI · 2015 · 31 citations
    9. Interventions for central serous chorioretinopathy: a network meta-analysis Cochrane library · 2015 · 87 citations
    10. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    11. Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus Heliyon · 2025
    12. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    13. The association of medications and supplements with human male reproductive health: a systematic review Fertility and Sterility · 2023 · 4 citations
    14. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. PubMed · 2012 · 13 citations
    15. Potential Medical Uses of Cannabigerol: A Brief Overview Elsevier eBooks · 2017 · 14 citations
    16. Pharmacology of anabolic steroids British Journal of Pharmacology · 2008 · 441 citations
    17. The significance of the apelinergic system in doxorubicin-induced cardiotoxicity Heart Failure Reviews · 2024 · 13 citations
    18. Carbonylation of hair proteins: A robust biomarker of molecular and structural oxidative damage in hair fibres International Journal of Cosmetic Science · 2025
    19. Medicinal Chemistry of Drugs with <i>N</i>-Oxide Functionalities Journal of Medicinal Chemistry · 2024 · 54 citations
    20. Finasteride reduces the preventive effect of uroselective α1A-blockers against cancellous bone disorders induced by androgen deficiency in rats Pharmacological Reports · 2015
    21. K channel therapeutics at the bedside Journal of Molecular and Cellular Cardiology · 2005 · 119 citations
    22. Potassium channel openers: therapeutic potential in cardiology and medicine Expert Opinion on Pharmacotherapy · 2001 · 25 citations
    23. Oral isotretinoin for acne Cochrane library · 2018 · 58 citations
    24. Ovarian surgery for symptom relief in women with polycystic ovary syndrome Cochrane library · 2017 · 21 citations
    25. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One Journal of Medicinal Chemistry · 2022 · 10 citations